Disodium Pamidronate Production Cost Reports

The report provides a detailed analysis essential for establishing a Disodium Pamidronate production plant. It encompasses all critical aspects necessary for Disodium Pamidronate production, including the cost of Disodium Pamidronate production, Disodium Pamidronate plant cost, Disodium Pamidronate production costs, and the overall Disodium Pamidronate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Disodium Pamidronate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Disodium Pamidronate is a bisphosphonate drug primarily used in the pharmaceutical industry for treating bone-related conditions. Its main applications include managing hypercalcemia caused by malignancies, treating moderate to severe Paget's disease of bone, and addressing osteolytic bone metastases associated with breast cancer and multiple myeloma.

It works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone loss, slowing bone destruction, and controlling elevated blood calcium levels. The compound is formulated as a sterile injectable solution for clinical use, often administered alongside standard antineoplastic therapy to alleviate bone complications and related symptoms such as bone pain and fractures.

The market for Disodium Pamidronate is primarily driven by the increasing global prevalence of bone-related disorders such as osteoporosis, Paget's disease, and hypercalcemia of malignancy. Ageing populations and advancements in cancer treatments, leading to higher survival rates, contribute significantly to sustained demand. Its use by pharmaceutical companies to manufacture injectable medications for these conditions drives its market growth. The major growth factors include innovations in drug formulation and delivery systems, expanding healthcare infrastructure in emerging markets such as China and India, and rising awareness of bone health.

Additionally, ongoing research into novel therapeutic applications and personalised medicine approaches further propels market expansion. However, regulatory emphasis on quality and safety, alongside efforts to diversify supply chains and enhance production capabilities, impacts industrial disodium pamidronate procurement.  Furthermore, market competition, including the availability of alternative bisphosphonates or novel bone therapy agents, further impacts price and supplier selection.

Raw Material for Disodium Pamidronate Production

According to the Disodium Pamidronate production plant project report, the various raw materials for Disodium Pamidronate production include pamidronic acid and sodium hydroxide.

Manufacturing Process of Disodium Pamidronate

The extensive Disodium Pamidronate production cost report consists of the following major industrial production process:

1. Production via neutralisation reaction: The production process of disodium pamidronate begins with the neutralisation of pamidronic acid using an aqueous sodium hydroxide solution until a clear solution forms, indicating conversion to the disodium salt. This solution is then filtered to remove insoluble impurities, and a suitable solvent is added. In the next step, water is subsequently removed by azeotropic distillation to concentrate the product and lower its moisture content. Finally, the solution is cooled, leading to the precipitation of disodium pamidronate.

Properties of Disodium Pamidronate

Disodium Pamidronate is a white to practically white powder, chemically known as disodium dihydrogen (3-amino-1-hydroxypropylidene) diphosphonate. Its molecular formula is C3H9NO7P2Na2 with a molecular weight of 279.1 (anhydrous form). It is highly soluble in water and in 2N sodium hydroxide, sparingly soluble in 0.1N hydrochloric acid and acetic acid, and practically insoluble in organic solvents. A 1% aqueous solution of disodium pamidronate has a pH around 8.3. The compound is often available as a pentahydrate form, which includes water of hydration roughly between 5 to 11%. It is stable and used primarily as a bisphosphonate agent to inhibit bone resorption by adsorbing to calcium phosphate crystals in bone. Its chemical structure facilitates strong binding to hydroxyapatite in bone, making it effective for pharmaceutical use in treating bone diseases.